NCT03708848View on ClinicalTrials.gov

Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

December 5, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Esomeprazole

Proton pump inhibitor

DRUG

Bismuth Potassium Citrate

Gastric mucosal protective drug with anti-H. pylori effect

DRUG

Clarithromycin

antibiotic for H. pylori eradication

DRUG

Metronidazole

antibiotic for H. pylori eradication

DRUG

Levofloxacin

antibiotic for H. pylori eradication

DRUG

Tetracycline

antibiotic for H. pylori eradication

Trial Locations (1)

200127

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT03708848 - Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy | Biotech Hunter | Biotech Hunter